$25.07
1.62% today
NYSE, Apr 02, 09:45 pm CET
ISIN
US2289031005
Symbol
AORT

CryoLife Target price 2025 - Analyst rating & recommendation

CryoLife Classifications & Recommendation:

Buy
100%

CryoLife Price Target

Target Price $32.33
Price $24.67
Potential
Number of Estimates 6
6 Analysts have issued a price target CryoLife 2026 . The average CryoLife target price is $32.33. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 6 analysts: 6 Analysts recommend CryoLife to buy, 0 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the CryoLife stock has an average upside potential 2026 of . Most analysts recommend the CryoLife stock at Purchase.

Sales and Margin forecast 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Million $ 388.54 423.70
9.76% 9.05%
EBITDA Margin 13.30% 20.06%
24.39% 50.79%
Net Margin -3.45% 0.17%
61.13% 104.92%

6 Analysts have issued a sales forecast CryoLife 2025 . The average CryoLife sales estimate is

$424m
Unlock
. This is
9.05% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$428m 10.16%
Unlock
, the lowest is
$420m 8.10%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $389m 9.76%
2025
$424m 9.05%
Unlock
2026
$469m 10.75%
Unlock
2027
$520m 10.87%
Unlock

5 Analysts have issued an CryoLife EBITDA forecast 2025. The average CryoLife EBITDA estimate is

$85.0m
Unlock
. This is
2.04% lower
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$86.5m 0.31%
Unlock
, the lowest is
$84.0m 3.19%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 $51.7m 36.53%
2025
$85.0m 64.44%
Unlock
2026
$98.9m 16.32%
Unlock
2027
$117m 18.49%
Unlock

EBITDA Margin

2024 13.30% 24.39%
2025
20.06% 50.79%
Unlock
2026
21.07% 5.03%
Unlock
2027
22.52% 6.88%
Unlock

6 CryoLife Analysts have issued a net profit forecast 2025. The average CryoLife net profit estimate is

$720k
Unlock
. This is
105.36% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$8.0m 159.37%
Unlock
, the lowest is
$-9.2m 31.24%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $-13.4m 57.33%
2025
$720k 105.36%
Unlock
2026
$16.8m 2,238.89%
Unlock
2027
$23.7m 40.74%
Unlock

Net Margin

2024 -3.45% 61.13%
2025
0.17% 104.92%
Unlock
2026
3.59% 2,011.76%
Unlock
2027
4.56% 27.02%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share $ -0.32 0.02
57.33% 106.25%
P/E 1,442.69
EV/Sales 3.18

6 Analysts have issued a CryoLife forecast for earnings per share. The average CryoLife EPS is

$0.02
Unlock
. This is
106.25% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
$0.19 159.38%
Unlock
, the lowest is
$-0.22 31.25%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $-0.32 57.33%
2025
$0.02 106.25%
Unlock
2026
$0.40 1,900.00%
Unlock
2027
$0.57 42.50%
Unlock

P/E ratio

Current -76.66 172.23%
2025
1,442.69 1,981.93%
Unlock
2026
61.46 95.74%
Unlock
2027
43.66 28.96%
Unlock

Based on analysts' sales estimates for 2025, the CryoLife stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 3.46 4.53%
2025
3.18 8.18%
Unlock
2026
2.87 9.70%
Unlock
2027
2.59 9.81%
Unlock

P/S ratio

Current 2.67 8.34%
2025
2.45 8.30%
Unlock
2026
2.21 9.71%
Unlock
2027
1.99 9.80%
Unlock

Current CryoLife Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Citizens Capital Markets
Locked
Locked
Locked Feb 25 2025
Needham
Locked
Locked
Locked Feb 25 2025
Stifel
Locked
Locked
Locked Feb 25 2025
Needham
Locked
Locked
Locked Jan 28 2025
JMP Securities
Locked
Locked
Locked Dec 10 2024
Needham
Locked
Locked
Locked Dec 09 2024
Oppenheimer
Locked
Locked
Locked Nov 08 2024
Analyst Rating Date
Locked
Citizens Capital Markets:
Locked
Locked
Feb 25 2025
Locked
Needham:
Locked
Locked
Feb 25 2025
Locked
Stifel:
Locked
Locked
Feb 25 2025
Locked
Needham:
Locked
Locked
Jan 28 2025
Locked
JMP Securities:
Locked
Locked
Dec 10 2024
Locked
Needham:
Locked
Locked
Dec 09 2024
Locked
Oppenheimer:
Locked
Locked
Nov 08 2024

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today